AF
CDNA icon

Amalgamated Financial’s CareDx CDNA Stock Holding History

Amalgamated Financial’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$305K Buy
+8,251
New +$322K ﹤0.01% 1726

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Amalgamated Financial's CDNA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in CareDx (CDNA) in Q1 2022: 8,251 shares worth $305K. The stake represents ﹤0.01% of the portfolio and ranks #1726 among its holdings.

213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Amalgamated Financial held 8,251 shares of CareDx worth $305K as of Q1 2022.
  • CareDx was a new Amalgamated Financial position in Q1 2022.
  • CareDx made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1726 holding.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.